Independent Intelligence for the U.S. Peptide Industry

Our Mission

USA Peptide Pros is an independent intelligence platform built for professionals operating in the U.S. peptide research and supply industry — suppliers, compounders, researchers, compliance officers, and procurement teams doing due diligence in a rapidly evolving regulatory environment.

We cover what matters to the industry: FDA regulatory developments, import alerts, supply chain disruptions, third-party testing standards, Certificate of Analysis verification practices, and market data. Our reporting is grounded in primary sources — regulatory filings, industry data, and direct interviews with compliance professionals.

We do not provide dosing information, self-administration guidance, or claims about the safety or efficacy of any compound for human use. This is a B2B trade publication, not a consumer resource.

What We Cover

Editorial Independence

Our editorial team operates independently from our advertising and sponsorship operations. Sponsored content is clearly labeled as "SPONSORED" or "ADVERTISEMENT" and is never presented as editorial coverage. Advertisers have no influence over our reporting, sourcing, or editorial decisions.

For a full description of our sourcing standards, correction policy, and sponsored-content labeling practices, see our Editorial Standards.

The Team

USA Peptide Pros was founded in 2024 by a team of regulatory affairs professionals and trade journalists with backgrounds in pharmaceutical supply chain, FDA compliance, and B2B media. Our editorial contributors include regulatory affairs editors, supply chain correspondents, and market intelligence analysts with direct industry experience.

We are based in the United States and focus exclusively on the domestic peptide research and supply market.